DQWS · DSwiss Inc
$0.03
At close · Sep 2
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements, for the period ended June 30, 2026, the Company’s current liabilities exceeded its current assets by $91,418, suffered an accumulated deficit of $1,463,001 and negative operating cash flow of $5,298. This factor raises substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.62M
Shares
206.90M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$2.92M
-6.2%
FY2025
Net Income
-$76.86K
-445.9%
FY2025
Gross Margin
19.33%
-0.7pp
FY2025
Operating Margin
-0.04%
0pp
FY2025
Diluted EPS
-$0.00
-500%
FY2025
Operating Cash Flow
-$94.3K
-151.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.89M | $2.92M | $3.11M | $1.47M | $1.85M | $1.96M | $1.35M | $273.66K | $220.12K | $181.4K | $137.18K | $154.97K | |
| $1.41M | $2.36M | $2.49M | $1.11M | $1.4M | $1.46M | $980.24K | $181.93K | $178.29K | $36.03K | $64.94K | $83.93K | |
| $481.45K | $564.56K | $623.27K | $359.23K | $444.99K | $499.12K | $367.48K | $91.73K | $41.83K | $145.37K | $72.24K | $71.04K | |
| — | 19.33% | 20.02% | 24.44% | 24.07% | 25.48% | 27.27% | 33.52% | 19% | 80.14% | 52.66% | 45.84% | |
| $685.75K | $630.65K | $603.72K | $367.65K | $402.41K | $308.69K | $288K | $242.16K | $236.65K | $204.55K | $394.87K | $80.14K | |
| $878 | $987 | $1034 | $1030 | $1029 | $1034 | $1040 | $2867 | $777 | $701 | $687 | — | |
| $79.33K | $63.85K | $17.56K | $64.93K | $72.44K | $65.38K | $65.64K | $62.66K | $24.04K | $26.46K | $19.8K | $18.65K | |
| — | — | — | — | — | — | — | $94.77K | $138.14K | $166.55K | $170.2K | $102.02K | |
| — | -$1167 | -$1203 | -$1342 | -$1303 | -$1464 | -$1216 | $295.46K | — | — | — | — | |
| — | -0.04% | -0.04% | -0.09% | -0.07% | -0.07% | -0.09% | 107.97% | — | — | — | — | |
| — | $62.69K | $16.36K | $63.59K | $71.14K | $63.92K | $64.43K | $358.13K | — | — | — | — | |
| -$68.15K | — | — | — | — | — | — | -$56.32K | -$46.45K | -$60.13K | -$23.21K | -$18.31K | |
| — | -$60.89K | $30.1K | — | — | — | — | — | — | — | — | — | |
| -$228.76K | -$60.89K | $30.1K | -$48.88K | -$2421 | $150.28K | $30.05K | -$295.46K | -$371.35K | -$284.89K | -$516.02K | -$129.32K | |
| $17.17K | $15.97K | $7878 | $657 | $516 | $176 | $2865 | — | — | — | — | -$26 | |
| -$245.94K | -$76.86K | $22.22K | -$49.54K | -$2937 | $150.1K | $27.18K | -$295.46K | -$371.35K | -$284.89K | -$516.02K | -$129.29K | |
| — | -2.63% | 0.71% | -3.37% | -0.16% | 7.66% | 2.02% | -107.97% | -168.7% | -157.05% | -376.16% | -83.43% | |
| -$20.16K | — | — | — | — | -$23.36K | $19.51K | -$9565 | -$20.04K | -$513 | $7953 | — | |
| -$257.9K | -$83.38K | $17.62K | $6763 | $12.85K | $168.65K | $14.06K | -$298.97K | — | — | — | — | |
| USD/shares | -$0.00 | -$0.00 | $0.00 | -$0.00 | -$0.00 | $0.00 | — | — | — | — | — | — |
| USD/shares | -$0.00 | -$0.00 | $0.00 | -$0.00 | -$0.00 | — | — | — | — | — | — | — |
| shares | — | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.43M | 203.46M | 64.03M |
| shares | — | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | 206.43M | 203.46M | 64.03M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 30 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Household & Personal Products median 1.74×
EV/EBIT
—
Household & Personal Products median 25.05×
P/E (TTM)
—
Household & Personal Products median 27.80×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Healthcare Products and Services | $2,920,986 | $3,112,887 | $1,470,071 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Malaysia | $2,920,986 | $3,112,887 | $1,470,071 | $1,849,047 | $1,958,655 | $1,192,837 |
| Hong Kong SAR China | — | — | — | — | — | $154,881 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Healthcare Products and Services | -$1,167 | -$1,203 | -$1,342 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Healthcare Products and Services | 0% | 0% | -0.1% |